Tag: Margetuximab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Margetuximab

Vanguard Group Inc. Has $48.68 Million Position in MacroGenics Inc (MGNX)

Added to Collection on: 2019-02-14 23:55:25

Tags for this article:

Money

Finance

Stock market

Click the tags to see associated articles and topics

View Article Details

MacroGenics Inc (MGNX) Director Matthew K. Fust Sells 6924 Shares

Added to Collection on: 2019-02-16 20:22:51

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

MacroGenics Inc (MGNX) Receives Consensus Rating of “Hold” from Brokerages

Added to Collection on: 2019-04-10 02:45:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics

Added to Collection on: 2020-12-13 17:26:15

Tags for this article:

NASDAQ COMPOSITE INDEX

Click the tags to see associated articles and topics

View Article Details

Global Trispecific Antibodies Market to 2024 - Opportunity & Clinical Trials Insights ...

Added to Collection on: 2020-12-15 17:03:45

Tags for this article:

Bispecific monoclonal antibody

Therapy

Biopharmaceutical

Margetuximab

Antibody-drug conjugate

Click the tags to see associated articles and topics

View Article Details

MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic ...

Added to Collection on: 2020-12-16 21:33:45

Tags for this article:

Trastuzumab emtansine

u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details

MacroGenics wins FDA approval of breast cancer drug

Added to Collection on: 2020-12-17 16:30:00

Tags for this article:

Breast cancer management

Metastatic breast cancer

Treatment of cancer

Trastuzumab emtansine

Roche

MacroGenics

Click the tags to see associated articles and topics

View Article Details

MacroGenics HER2 drug scores FDA breast cancer nod with Herceptin-topping data

Added to Collection on: 2020-12-17 16:30:00

Tags for this article:

Antibody-drug conjugate

Metastatic breast cancer

Trastuzumab emtansine

MacroGenics

Click the tags to see associated articles and topics

View Article Details

The Plethora of Clinical Trials Explore Gastric Cancer Treatments: A Status Review by DelveInsight

Added to Collection on: 2021-05-05 00:00:00

Tags for this article:

Infectious causes of cancer

Eli Lilly and Company

Apatinib

United States

Click the tags to see associated articles and topics

View Article Details

Expert Insights: Later-Line Treatment Strategies for HER2+ Metastatic Breast Cancer

Added to Collection on: 2025-07-08 13:19:16

Tags for this article:

Trastuzumab emtansine

Margetuximab

Trastuzumab

Antibody-drug conjugate

Pertuzumab

Tucatinib

Click the tags to see associated articles and topics

View Article Details

Tag: Margetuximab

Recent Related Articles to Margetuximab

Vanguard Group Inc. Has $48.68 Million Position in MacroGenics Inc (MGNX)

MacroGenics Inc (MGNX) Director Matthew K. Fust Sells 6924 Shares

MacroGenics Inc (MGNX) Receives Consensus Rating of “Hold” from Brokerages

2 IPOs Plus FDA Decisions On Moderna's COVID Vaccine And Drugs From Amgen, MacroGenics

Global Trispecific Antibodies Market to 2024 - Opportunity & Clinical Trials Insights ...

MacroGenics Announces FDA Approval of MARGENZA™ for Patients with Pretreated Metastatic ...

MacroGenics wins FDA approval of breast cancer drug

MacroGenics HER2 drug scores FDA breast cancer nod with Herceptin-topping data

The Plethora of Clinical Trials Explore Gastric Cancer Treatments: A Status Review by DelveInsight

Expert Insights: Later-Line Treatment Strategies for HER2+ Metastatic Breast Cancer

Create dashboard for Tag: Margetuximab